Simvastatin protects against the development of endometriosis in a nude mouse model

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2489-2494

  Bruner Tran, Kaylon L ^a   Osteen, Kevin G ^a   Duleba, Antoni J ^b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; INTERLEUKIN 1ALPHA; SIMVASTATIN; STROMELYSIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG CAPSULE; DRUG EFFECT; DRUG MECHANISM; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; ENDOMETRIUM CELL; EVALUATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPLANT; INJECTION; LABORATORY; MOUSE; NONHUMAN; NUDE MOUSE; ORGAN CULTURE; OVARIECTOMY; PRIORITY JOURNAL; PROTECTION; TREATMENT DURATION;

MUS; MUS MUSCULUS;

EID: 67650260822     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2802     Document Type: Article

References (39)

1. Houston DE 1984 Evidence for the risk of pelvic endometriosis by age, race and socioeconomic status. Epidemiol Rev 6:167-191
2. Propst AM, Laufer MR 1999 Endometriosis in adolescents. Incidence, diagnosis and treatment. J Reprod Med 44:751-758
3. Mahmood TA, Templeton A 1991 Prevalence and genesis of endometriosis. Hum Reprod 6:544-549
4. Simoens S, Hummelshoj L, D'Hooghe T 2007 Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 13:395-404
5. Spuijbroek MD, Dunselman GA, Menheere PP, Evers JL 1992 Early endometriosis invades the extracellular matrix. Fertil Steril 58:929-933
6. Osteen KG, Yeaman GR, Bruner-Tran KL 2003 Matrix metalloproteinases and endometriosis. Semin Reprod Med 21:155-164
7. Van Langendonckt A, Casanas-Roux F, Donnez J 2002 Oxidative stress and peritoneal endometriosis. Fertil Steril 77:861-870
8. Santanam N, Murphy AA, Parthasarathy S 2002 Macrophages, oxidation, and endometriosis. Ann NY Acad Sci 955:183-198
9. Foyouzi N, Berkkanoglu M, Arici A, Kwintkiewicz J, Izquierdo D, Duleba AJ 2004 Effects of oxidants and antioxidants on proliferation of endometrial stromal cells. Fertil Steril 82(Suppl 3):1019-1022
10. Franzoni F, Quiñones-Galvan A, Regoli F, Ferrannini E, Galetta F 2003 A comparative study of the in vitro antioxidant activity of statins. Int J Cardiol 90:317-321
11. Rombouts K, Kisanga E, Hellemans K, Wielant A, Schuppan D, Geerts A 2003 Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. J Hepatol 38:564-572
12. Danesh FR, Sadeghi MM, Amro N, Philips C, Zeng L, Lin S, Sahai A, Kanwar YS 2002 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: implications for diabetic nephropathy. Proc Natl Acad Sci USA 99:8301-8305
13. Mattingly RR, Gibbs RA, Menard RE, Reiners Jr JJ 2002 Potent suppression of proliferation of a10 vascular smooth muscle cells by combined treatment with lovastatin and 3-allylfarnesol, an inhibitor of protein farnesyltransferase. J Pharmacol Exp Ther 303:74-81
14. Piotrowski PC, Kwintkiewicz J, Rzepczynska IJ, Seval Y, Cakmak H, Arici A, Duleba AJ 2006 Statins inhibit growth of human endometrial stromal cells independently of cholesterol availability. Biol Reprod 75:107-111
15. Esfandiari N, Khazaei M, Ai J, Bielecki R, Gotlieb L, Ryan E, Casper RF 2007 Effect of a statin on an in vitro model of endometriosis. Fertil Steril 87:257-262
16. Oktem M, Esinler I, Eroglu D, Haberal N, Bayraktar N, Zeyneloglu HB 2007 High-dose atorvastatin causes regression of endometriotic implants: a rat model. Hum Reprod 22:1474-1480
17. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG 1997 Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 99:2851-2857
18. Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J, Osteen KG 2002 Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 87:4782-4791
19. Bruner-Tran KL, Zhang Z, Eisenberg E, Winneker RC, Osteen KG 2006 Downregulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget. J Clin Endocrinol Metab 91:1554-1560
20. Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD, Fan TP, Smith SK 2003 Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 88:2889-2899
21. Bouterfa HL, Sattelmeyer V, Czub S, Vordermark D, Roosen K, Tonn JC 2000 Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells. Anticancer Res 20:2761-2771
22. Li X, Liu L, Tupper JC, Bannerman DD, Winn RK, Sebti SM, Hamilton AD, Harlan JM 2002 Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells. J Biol Chem 277:15309-15316
23. Khwaja A, Sharpe CC, Noor M, Hendry BM 2006 The role of geranylgeranylated proteins in human mesangial cell proliferation. Kidney Int 70:1296-1304
24. Nap AW, Dunselman GA, de Goeij AF, Evers JL, Groothuis PG 2004 Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model. Hum Reprod 19:2180-2187
25. Lazzerini PE, Capecchi PL, Nerucci F, Fioravanti A, Chellini F, Piccini M, Bisogno S, Marcolongo R, Laghi Pasini F 2004 Simvastatin reduces MMP-3 level in interleukin 1β stimulated human chondrocyte culture. Ann Rheum Dis 63:867-869
26. Wilson WR, Evans J, Bell PR, Thompson MM 2005 HMG-CoA reductase inhibitors (statins) decrease MMP-3 and MMP-9 concentrations in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 30:259-262
27. Furman C, Copin C, Kandoussi M, Davidson R, Moreau M, McTaggiart F, Chapman MJ, Fruchart JC, Rouis M 2004 Rosuvastatin reduces MMP-7 secretion by human monocyte-derived macrophages: potential relevance to atherosclerotic plaque stability. Atherosclerosis 174:93-98
28. Cho SJ, Kim JS, Kim JM, Lee JY, Jung HC, Song IS 2008 Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer 123:951-957
29. Boodhwani M, Mieno S, Feng J, Sodha NR, Clements RT, Xu SH, Sellke FW 2008 Atorvastatin impairs the myocardial angiogenic response to chronic ischemia in normocholesterolemic swine. J Thorac Cardiovasc Surg 135:117-122
30. Shishehbor MH, Brennan ML, Aviles RJ, Fu X, Penn MS, Sprecher DL, Hazen SL 2003 Statins promote potent systemic antioxidant effects through specific inflammatory pathways. Circulation 108:426-431
31. Rajkumar K, Schott PW, Simpson CW 1990 The rat as an animal model for endometriosis to examine recurrence of ectopic endometrial tissue after regression. Fertil Steril 53:921-925
32. Rogers SL, Magliano DJ, Levison DB, Webb K, Clarke PJ, Grobler MP, Liew D 2007 A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin. Clin Ther 29:242-252
33. Gresser U, Gathof BS 2004 Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies. Eur J Med Res 9:1-17
34. Turner NA, Midgley L, O'Regan DJ, Porter KE 2007 Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. J Cardiovasc Pharmacol 50:458-461
35. Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G 1999 Stimulation of bone formation in vitro and in rodents by statins. Science 286:1946-1949
36. Ni W, Egashira K, Kataoka C, Kitamoto S, Koyanagi M, Inoue S, Takeshita A 2001 Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. Circ Res 89:415-421
37. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H, Zeiher AM 2001 HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108:391-397
38. Kita T, Brown MS, Goldstein JL 1980 Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J Clin Invest 66:1094-1100
39. Grümmer R, Schwarzer F, Bainczyk K, Hess-Stumpp H, Regidor PA, Schindler AE, Winterhager E 2001 Peritoneal endometriosis: validation of an in-vivo model. Hum Reprod 16:1736-1743